Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T4469 |
Nemorubicin
Methoxymorpholinyldoxorubicin,PNU-152243A,PNU 152243,奈莫柔比星 |
Others | Others |
Nemorubicin (PNU 152243) 是一种 Doxorubicin 衍生物,具有抗肿瘤活性。它需要完整的核苷酸切除修复系统才能发挥活性。它对多药耐药表型的多种肿瘤细胞系具有细胞毒性。 | |||
T71467 |
Nemorubicin HCL
|
||
Nemorubicin HCL is the salt form of Nemorubicin, also known as PNU152243A, a doxorubicin derivative that differs significantly from its parent drug in terms of spectrum of antitumor activity, metabolism and toxicity profile. The drug is active on tumors resistant to alkylating agents, topoisomerase II inhibitors and platinum derivatives. It works primarily through topoisomerase I inhibition. Of note, Nemorubicin is active in cells with upregulation of the nucleotide excision repair (NER) pathway... |